Clinical Trial Update: The KHENERGYZE Study [Phase 2]

View source ↗

Summary

Phase 2 trial update for the KHENERGYZE study investigating a treatment for mitochondrial diseases and mitochondrial myopathies (including MELAS and MIDD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Maternally Inherited Diabetes and Deafness
• Melas Syndrome
• Mitochondrial Diseases
• Mitochondrial Myopathies

Snippet

Sponsor: Khondrion BV | Conditions: Mitochondrial Diseases, Mitochondrial Myopathies | Phase 2 | Status: COMPLETED